Delivery Order SPE2DR25D3301-SPE2DR26F18ED
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on June 3, 2025, for Twinrix vaccine syringes valued at $2,162.19. This competitively awarded, firm fixed-price delivery order is set to be completed by June 4, 2025, and represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Twinrix vaccine in syringe form, with a ceiling value of $2,044.19 and an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $31,972.39 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This firm fixed price, competitively awarded contract was issued on October 21, 2025, with an ultimate completion date of October 22, 2025. The deliverables will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a $12,530.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, with an ultimate completion date of November 17, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.80 to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on September 22, 2025, with an ultimate completion date of September 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,215.76 to AmerisourceBergen Drug Corp for TWINRIX vaccine syringes, with an ultimate completion date of October 31, 2025. This is a firm fixed price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Twinrix vaccine in syringe format, with a contract ceiling value of $2,140.77. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order is scheduled for completion by September 24, 2025, and represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $1,057.11 and an ultimate completion date of September 19, 2025. This is a firm fixed-price, non-set-aside contract, representing a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $7,734.62 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Twinrix vaccine syringes. This non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18EDDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 17, 2025, by the Defense Logistics Agency for the supply of Twinrix vaccine in syringe format. The contract represents a firm fixed-price delivery order with a ceiling value of $2,073.96 and an ultimate completion date of November 18, 2025. This award was competitively awarded with no set-aside designation and is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order supports the Defense Logistics Agency's medical supply chain operations, which provide pharmaceutical products and medical supplies to military and veteran healthcare systems. As a critical vendor in the federal procurement landscape, AmerisourceBergen leverages its comprehensive IDC to fulfill specialized medical commodity requirements across multiple therapeutic domains. The firm fixed-price structure and compressed delivery timeline reflect the urgent nature of vaccine procurement for Defense Health Agency operations and other military healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/17/25 |